Obsidian Therapeutics Inc.

Last updated September 27, 2026

Organization details

Legal name
Obsidian Therapeutics Inc.
Former names
Gazelle Parent, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Headquarters city
Cambridge
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
OBX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002130606
EIN
42-1977778

Board of directors

Chief executives

Madan Jagasia · Chief Executive Officer
Since August 2026

Board connections

4 of this board's directors also sit on 4 other boards. 3 are in the same sector.

Network of Obsidian Therapeutics Inc.'s board connections CRISPR Therapeutics AG CRISPR Therapeutics AG Revvity Inc. Revvity Inc. Vericel Corporation Vericel Corporation Xilio Therapeutics Inc. Xilio Therapeutics Inc... Heidi Hagen Heidi Hagen Maria Fardis Maria Fardis Peter Barrett Peter Barrett Robert W. Ross Robert W. Ross Obsidian Therapeutics Inc.
Shared director Other board Same sector

Organizations in the same sector, closest in location and size first.

Questions about Obsidian Therapeutics Inc.

Who is the CEO of Obsidian Therapeutics Inc.?

Madan Jagasia has been Obsidian Therapeutics Inc.'s Chief Executive Officer since August 2026.

How many directors are on Obsidian Therapeutics Inc.'s board?

Obsidian Therapeutics Inc.'s board has 6 directors: Heidi Hagen, Madan Jagasia, Maria Fardis, Matthew Norkunas, Peter Barrett and Robert W. Ross.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="obsidian-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.